Anesthesiology · 2013 · 150 citations · 31 references
Life SciencesNeurosciencePharmacologyDevelopmental NeuroscienceMolecular NeuroscienceNeuropharmacologyGlutamatergic PharmacologyNeuroprotectionNeurotrophic FactorsAdrenergic Receptor AgonistsAdrenergic Receptor SignalingAlpha-adrenergic AgonistsExtracellular Signal-regulated Kinase PathwayExtracellular Signal-regulated Kinase SignalingGlutamate-induced NeurotoxicityGlutamatergic NeuroprotectionNeuroprotective Agents
BACKGROUND: Brain-derived neurotrophic factor (BDNF) plays a prominent role in neuroprotection against perinatal brain injury. Dexmedetomidine, a selective agonist of α2-adrenergic receptors, also provides neuroprotection against glutamate-induced damage. Because adrenergic receptor agonists can modulate BDNF expression, our goal was to examine whether dexmedetomidine's neuroprotective effects are mediated by BDNF modulation in mouse perinatal brain injury. METHODS: The protective effects against glutamate-induced injury of BDNF and dexmedetomidine alone or in combination with either a neutralizing BDNF antibody or an inhibitor of the extracellular signal-regulated kinase pathway (PD098059) were compared in perinatal ibotenate-induced cortical lesions (n = 10-20 pups/groups) and in mouse neuronal cultures (300 μM of ibotenate for 6 h). The effect of dexmedetomidine on BDNF expression was examined in vivo and in vitro with cortical neuronal and astrocyte isolated cultures. RESULTS: Both BDNF and dexmedetomidine produced a significant neuroprotective effect in vivo and in vitro. Dexmedetomidine enhanced Bdnf4 and Bdnf5 transcription and BDNF protein cortical expression in vivo. Dexmedetomidine also enhanced Bdnf4 and Bdnf5 transcription and increased BDNF media concentration in isolated astrocyte cultures but not in neuronal cultures. Dexmedetomidine's protective effect was inhibited with BDNF antibody (mean lesion size ± SD: 577 ± 148 μm vs. 1028 ± 213 μm, n = 14-20, P < 0.001) and PD098059 in vivo but not in isolated neuron cultures. Finally, PD098059 inhibited the increased release of BDNF induced by dexmedetomidine in astrocyte cultures. CONCLUSION: These results suggest that dexmedetomidine increased astrocyte expression of BDNF through an extracellular signal-regulated kinase-dependent pathway, inducing subsequent neuroprotective effects.
31
Vesna Jevtović‐Todorović, Richard E. Hartman, Yukitoshi Izumi et al. · Journal of Neuroscience · 2003 · 2K citations · Full text
Activation of p75NTR by proBDNF facilitates hippocampal long-term depression
Newton H. Woo, Henry Teng, Chia-Jen Siao et al. · Nature Neuroscience · 2005 · 802 citations
Jianmin Yang, Chia-Jen Siao, Guhan Nagappan et al. · Nature Neuroscience · 2009 · 444 citations